Shield Therapeutics Share Discussion Threads

[fishboy] 08/11/2024 21:54

Hoping a large drug company will now step in and see potential STX has in Iron deficiency and perhaps more so potential drugs in their pipeline.

[fishboy] 08/11/2024 21:32

Now, thinking STX and large shareholder of 40 to 50% are making decisions about outcome.

[fishboy] 08/11/2024 21:17

Defo a seller over last 3 weeks, driving it down, I thought numbers were adequate to maintain a share price between 4 to 5p

[fishboy] 08/11/2024 21:14

I noticed that post, is that yours Patty.

[purchaseatthetop] 08/11/2024 18:17

Valid and interesting post on LSE

“jimie
Posts: 4
Price: 2.75
No Opinion
Q4 Growth RateToday 13:38
Q4 TX growth will be key.

Quarterly Tx increases have been a follows:

2023 Q2 +4450, Q3 +8350, Q4 +5350

2024Q2 +7600, Q3 +7100

Following the release of 24'Q2 results, Hardman had forecasted Shield achieving 173k total in 2024. But that means they would need an increase of 20,800 over Q3 (64300) in Q4, which I think is very unlikely indeed.

More likely they will end the year with 110-120k. This is what they had originally hoped for in 2023, so you could say they are a full year behind.

But getting 5000-7000 extra tx each quarter would mean it will take an age to get somewhere making a decent profit.

Unless Q4 or Q1'25 is when we finally see sales traction???”

Points to consider….
1) fully agree that the growth rate of only about 7k a quarter means extrapolating the growth correctly says a long time to mega profits. However, the Rx was only $120 a couple of quarters ago. They accepted slower growth for higher $ per prescription.

2) not sure where the 110-120k comes from. Q1 28k, Q2 36k, Q3 43k. That is 97k so far and around 51k Q4 remakes 150k.

3) the rest of the world should expand in 2025. Europe, Korea, China, new territories. It is not just USA though that is crucial.

Even with 100 sales persons that is only 2 per US state. That was always the problem. Might take a while to get traction.

[parob] 08/11/2024 09:24

Has PATT sold and stopped posting?The 250K sales have stopped.

[qipincha] 06/11/2024 22:26

Since applied filter, I have a peaceful mind

[zeus19] 06/11/2024 20:51

PATTS BIGGEST FAN ALERT!

[fishboy] 06/11/2024 19:21

Any idea when STX are doing the issue of new shares for fund raise.

Hoping a big pharma will step in before, bit of a shambles - handled bad by STX and their corporate broker, left market in doubts, hence drift in share price.

[weatherman] 06/11/2024 16:49

A clear election victory should mean stable markets for STX.

[purchaseatthetop] 06/11/2024 16:04

Certainly there is a regular 250k seller. Has been for days now.

[zeus19] 06/11/2024 16:02

PATT biggest fan club member, little girl. Dance for me b*tch

[lako42] 06/11/2024 09:54

What the hell makes you think anyone listens to what nutters on here are saying in regards to investment decisions? This includes yourself seeing as you are obsessed with a certain individual.

Grow up you fool

[lako42] 06/11/2024 08:28

A stronger dollar should give us a little boost

[purchaseatthetop] 05/11/2024 17:04

This share price is ridiculous. 2025 will have any number of boosting RNSs with Korean, Canada, paediatric, China and every quarter US product grows. When Q4 24 data arrives showing around 51k at $190 and Q4 revenues of $11.5m things will change.

Q4 24 US Accrufer income at 51k by $190 would be $9.7m. They did $11.5m in the whole of 2023! Whatever you say that shows the progress.